KRAS and lung cancer: While antioxidants may slow tumor progression in specific cancers such as MYC-driven lymphoma, they can accelerate tumor growth, metastasis, and angiogenesis in other settings, including KRAS-driven lung cancer and BRAF-driven melanoma.